Skip to main navigation
  • Contact
Aimmune
Menu CLOSE X
CLOSE X
  • About Aimmune
    • Company Overview
    • History
    • Leadership
    • Culture of Integrity
  • Our Product
    • Our Product
    • Expanded Access Policy
  • Our Pipeline
    • Our Pipeline
    • Our Focus
  • Media
    • Press Releases
  • Careers
    • Career Opportunities
  • Contact

Press Releases

Keyword Search

Recent News

December 21, 2020
European Commission Approves Aimmune’s PALFORZIA® as First-Ever Treatment for Peanut Allergy in the EU
October 16, 2020
Aimmune Receives Positive CHMP Opinion on PALFORZIA® for the Treatment of Patients with Peanut Allergy in Europe
October 14, 2020
Nestlé Completes Acquisition of Aimmune Therapeutics
August 31, 2020
Aimmune Agrees to be Acquired by Nestlé Health Science
August 24, 2020
Largest European Qualitative Study on Peanut Allergy Highlights Negative Impact of Avoidance and Fear of Accidental Peanut Allergy Reactions on Allergic Individuals and Their Caregivers
August 7, 2020
Aimmune Therapeutics to Present at the 2020 Wedbush PacGrow Healthcare Virtual Conference
July 30, 2020
Aimmune Therapeutics Announces Second Quarter 2020 Financial Results and Provides Recent Operational Highlights
July 23, 2020
Aimmune Therapeutics to Host Conference Call and Webcast to Discuss Second Quarter 2020 Financial Results and Recent Operational Highlights
July 21, 2020
Full Results of Aimmune’s Pivotal Phase 3 European ARTEMIS Trial of PALFORZIA® Published in The Lancet Child & Adolescent Health
July 6, 2020
Aimmune Appoints Narinder Singh as Executive Vice President of Technical Operations

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Next page next ›
  • Last page last »

Media Contacts

Julie Normart
559-974-3245
jnormart@w2ogroup.com

Lauren Barbiero
646-564-2156
lbarbiero@w2ogroup.com

Email Alerts

About Aimmune
  • Company Overview
  • History
  • Leadership
  • Culture of Integrity
Our Product
  • Our Product
  • Expanded Access Policy
Our Pipeline
  • Our Pipeline
  • Our Focus
Media
  • Press Releases
Careers
  • Career Opportunities
© 2020 Aimmune Therapeutics. All rights reserved.
  •  
  • Terms of Use
  • Privacy Policy
  • Privacy Shield
  • Twitter Guidelines
  • Facebook Guidelines